Original article
Auszug aus dem ePaper des Arzneimittelreports 2024 zum Thema „HPV-Impfung”
01.10.2024
In recent years, prescription requirements for numerous active ingredients have been lifted at the national and international levels (e.g., triptans, antihistamines, or H2 receptor antagonists). The triage criteria for this are „[…] safe and easy use, [the] strengthening of patient responsibility, and [an] improved quality of life“ (1). Self-medication with prescriptions from pharmacies can also lead to positive effects for the healthcare system (2).
01.10.2024
The authors of a study [1] that extrapolated the potential effects of various tax models, including a tiered manufacturer's levy on sugary drinks, concluded that such a tax would have some effects in Germany between 2023 and 2043 (see box: "Expected Effects"). Professional societies such as the German Diabetes Society (DGS) are calling for the introduction of such a tax, claiming that its benefits have been proven. This study evaluates the plausibility and value of the observational studies used for the optimistic calculations in [1].
01.10.2024
Interview with Prof. Dr. Jochen A. Werner, Medical Director and Chairman of the Board of Directors of Essen University Hospital.
01.10.2024
Comment by Dr. Michael Brinkmeier, Chairman of the Board of the German Stroke Foundation
01.10.2024
Commentary by Prof. Dr. rer. nat. Andreas Radbruch, German Rheumatism Research Center Berlin, a Leibniz Institute
01.10.2024
Series (Part 43): Center for Medical Services Research at the University Hospital Erlangen
01.10.2024
Focus: the specialty pharmaceutical market
01.10.2024
Where and with what success are vaccinations administered? This was the topic of the 7th MVF Vaccination Congress, entitled "Vaccination Status 2024," which—as in previous online congresses—focused on how to actually increase vaccination rates. These rates are generally poor, meaning too low, and in many cases, far too low. This applies to many vaccine-preventable diseases, including influenza, measles, and RSV, an infection that can cause serious complications such as cardiovascular events and for which entirely new vaccination options are available.
01.10.2024
Commentary by Prof. Dr. Josef Franz Lindner, Chair of Public Law, Medical Law and Legal Philosophy, Faculty of Law, University of Augsburg